MichaelStevenSimonMDMPH

Oncology • Detroit, MI

Hematologic Oncology

Professor, Oncology, Karmanos Cancer Institute at Wayne State University SOM

Join to view full profile

Dr. Simon is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Simon's full profile

Already have an account?

Office
4100 John R Hwcrc 4th Fl
Karmanos Cancer Center
Detroit, MI 48201
Phone+1 800-527-6266

Fax+1 313-576-8767

Education & Training

University of MichiganFellowship, Hematology and Medical Oncology, 1986 - 1989
University of MichiganMPH, Epidemiology, 1986 - 1989
University of MichiganResidency, Internal Medicine, 1983 - 1985
University of Illinois College of MedicineClass of 1983

Certifications & Licensure

MI State Medical License 1984 - 2027
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

30 year Service Award Wayne State University, 2019
Best Doctors in America 2017
College Teaching Award Wayne State University, 2004, 2011, 2014, 2017
Charles C Shepard Science Award Centers for Disease Control, 2003
Join now to see all

Clinical Trials

Weight Loss Counseling for African American Women Who Are Breast Cancer Survivors Start of enrollment: 2004 May 01
Completed
Laboratory-Treated T Cells After Second-Line Chemotherapy in Treating Patients With HER2/Neu-Negative Metastatic Breast Cancer Start of enrollment: 2010 Mar 08
Terminated
Phase 2
Targeted T Cells After Neoadjuvant Chemotherapy in Treating Women With Stage II or III Breast Cancer Undergoing Surgery Start of enrollment: 2010 Jul 01
Terminated
Phase 2
Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer Start of enrollment: 2015 Jul 26
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

1 citations
Association of clonal hematopoiesis and mosaic chromosomal alterations with solid malignancy incidence and mortality.
Pinkal Desai, Ying Zhou, Justin Grenet, Samuel K Handelman, Cynthia M Crispino
Cancer. 2024-11-15
Social Support, Social Strain, Stressful Life Events and Mortality Among Postmenopausal Women With Breast Cancer.
Fengge Wang, Michael S Simon, Candyce H Kroenke, Jessica Krok-Schoen, Su Yon Jung
Psycho-Oncology. 2024-11-01
Estrogen Plus Progestin and Colorectal Cancer: Long-Term Findings From the Women's Health Initiative Randomized Clinical Trial.
Rowan T Chlebowski, Aaron K Aragaki, Kathy Pan, Juhua Luo, Thomas E Rohan
Journal of Clinical Oncology. 2024-10-20

Abstracts/Posters

Antecedent Clonal Hematopoesis and Risk of and Mortality after Solid and Hematological Malignancies: Analyses from the Women's Health Initiative Study
Michael S. Simon, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

Cardiometabolic risk factors and survival after cancer in the womenâ€™s health initiative.
2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

Tigers Fans Joined Karmanos and McLaren, Dressed in Pink to Honor Breast Cancer Survivors and Fighters Across MichiganMay 25th, 2023
Karmanos Cancer Institute to Hold Health Equity Book Club Discussion March 25March 17th, 2021
OncLive® to Host State of the Science Summit™ on Breast CancerMay 8th, 2018
Join now to see all

Committees

Chair, Crendtialing Committee Karmanos Cancer Instittute 2009 - Present

Research History

Women's Health InitiativeChair Cancer Special Interest Group2017 - Present

Professional Memberships

Industry Relationships

Speaker Bureau, Astra ZenecaSpeaker for Cancer Genetic Testing2019 - Present